Danaher
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Danaher 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DHR
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics.
CEORainer M. Blair
CEORainer M. Blair
Employees63,000
Employees63,000
HeadquartersWashington, District of Columbia
HeadquartersWashington, District of Columbia
Founded1984
Founded1984
Employees63,000
Employees63,000
DHR Key Statistics
Market cap162.75B
Market cap162.75B
Price-Earnings ratio47.42
Price-Earnings ratio47.42
Dividend yield0.56%
Dividend yield0.56%
Average volume2.28M
Average volume2.28M
High today$232.10
High today$232.10
Low today$227.23
Low today$227.23
Open price$228.83
Open price$228.83
Volume2.34M
Volume2.34M
52 Week high$258.23
52 Week high$258.23
52 Week low$171.00
52 Week low$171.00
Stock Snapshot
Danaher(DHR) stock is priced at $230.40, giving the company a market capitalization of 162.75B. It carries a P/E multiple of 47.42 and pays a dividend yield of 55.6%.
During the trading session on 2026-01-04, Danaher(DHR) shares reached a daily high of $232.10 and a low of $227.23. At a current price of $230.40, the stock is +1.4% higher than the low and still -0.7% under the high.
Trading volume for Danaher(DHR) stock has reached 2.34M, versus its average volume of 2.28M.
Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.
Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $258.23 and a low of $171.00.
Analyst ratings
86%
of 29 ratingsBuy
86.2%
Hold
13.8%
Sell
0%
People also own
Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.